Theodore Workman, MD
Interventional Pain Medicine · Redding, CANPI 1316970031
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,495 of the $13,017 with a category attached, or 65.3%. 23 manufacturers reported payments, led by Boston Scientific at 31.8% of the total. Reporting peaked in 2024 at $3,552 and has fallen 66.1% since, to $1,204 in 2025.
Across 292 payments — averaging $44.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Spinal Simplicity, LLC$2K
- Curonix LLC$1K
- Abbott$1K
- Vertos Medical, Inc.$1K
- SPR Therapeutics, Inc$896
- plus $2K from 17 others
What the payments were for
- Travel & lodging$3,06724%
- Food & beverage$8,49565%
- Education$1,45611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 153 | $4,139 |
| Spinal Simplicity, LLC | 7 | $2,059 |
| Curonix LLC | 12 | $1,465 |
| Abbott | 40 | $1,316 |
| Vertos Medical, Inc. | 7 | $1,268 |
| SPR Therapeutics, Inc | 7 | $896 |
| Nevro Corp. | 33 | $889 |
| Tersera Therapeutics LLC | 3 | $177 |
| Medtronic(2 entities) | 5 | $148 |
| Painteq LLC | 2 | $148 |
| Relievant Medsystems, Inc. | 3 | $128 |
| AbbVie(2 entities) | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Stimwave Technologies Incorporated | 1 | $51 |
| Johnson & Johnson | 2 | $46 |
| Bioventus LLC | 2 | $34 |
| Biodelivery Sciences International, Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Almatica Pharma LLC | 1 | $21 |
| Pfizer | 1 | $16 |
| Amgen | 1 | $15 |
| Avanos Medical | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,017 in reported general payments places this provider in the 80th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $593 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $204 |
| Oxycodone Hcl | 55 | $183 |
| Hydromorphone Hcl | 34 | $150 |
| Mupirocin | 18 | $115 |
| Tramadol Hcl | 55 | $71 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Redding
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.